Organized by Ben Zeskind, PhD, MBA, Co-Founder and CEO of Immuneering Corp and moderated by Rudolph E. Tanzi, PhD, of the Massachusetts ADRC, the event will consist of a panel of individuals supporting and conducting Alzheimer's Disease R & D efforts in academia, industry and start-ups.
Registration is from 5:30pm - 6:10pm. The panel discussion will be held from 6:10pm - 8pm, followed by a reception and networking event from 8 - 9 pm.
MIT Enterprise Forum
Email: mitefcmb [ at ] mit [dot] edu